Tuesday, 24 September 2013

Agrylin


Generic name/Active ingredient: Anagrelide hydrochloride 0.5 mg
Trade name: Agrylin
Dosage form: Capsule
Drug classification: Antineoplastic, phosphodiesterase 3 inhibitor
Legal classification: POM
Company: Shire US Inc
Commonly used for: Treatment of essential thrombocytosis, chronic myeloid leukemia